Global Caprylhydroxamic Acid Market Overview:
Caprylhydroxamic Acid (CHA) is also known as octanohydroxamic acid, N-Hydroxyoctanamide, taselin, or caprylohydroxamic acid. It is an amino acid obtained from coconut oil. It is a preservative and anti-fungal agent with a high pH level. This acid is used as a chelating agent in personal care products. This acid is compatible with the most cosmetic ingredients. This acid is a bactericide and an ample spectrum anti-fungal agent. The growing use of caprylhydroxamic acid in skincare products is driving market growth.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Forecast Period | 2023-2028 |
Historical Period | 2018-2022 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Demand for Anti-Aging Skin Care Products
Market Growth Drivers:
Increasing Demand from the Pharmaceutical Sector and Rising Use of Caprylhydroxamic Acid as a Substitute for Parabens
Challenges:
Availability of Substitute Acids
Restraints:
Fluctuating Raw Material Price
Opportunities:
Growing Coconut Production Worldwide and Growing Preference for Non-toxic Preservatives in Personal Care Industry
Competitive Landscape:
In the caprylhydroxamic acid market, it has been observed to be highly contentious. Most of the companies are upgrading or introducing innovative products. The key players in the market and new entrants keep on investing in research and developments related to the market. They are adopting strategies such as mergers & acquisitions, product development, geographical expansion, technological innovation and sourcing strategies to enhance their market share.
Some of the key players profiled in the report are INOLEX, Inc. (Pennsylvania), Carbone Scientific CO.,LTD (United Kingdom), Ark Pharm, Inc. (United States), TCI Chemicals Pvt. Ltd. (India), 3B Scientific Corporation (United States), HBCChem, Inc. (United States), Hangzhou Lingeba Technology Co., Ltd (China), Beijing Yunbang Biosciences Co.,Ltd (China), Sichuan Nanbu Honest and Creditable Science-tech Ltd (China), BePharm Ltd. (China), Shanghai Yolen Co. Ltd (China), Hunan Hecheng Pharmaceutical Chemical Co., Ltd. (China) and Chengdu DingDang Pharmaceutical Co., Ltd. (China). Analyst at AMA Research see Asia Pacific Vendors to retain maximum share of Global Caprylhydroxamic Acid market by 2028. Considering Market by Appearance, the sub-segment i.e. White Powder will boost the Caprylhydroxamic Acid market. Considering Market by Grade Type, the sub-segment i.e. Cosmetic Grade will boost the Caprylhydroxamic Acid market.
In 2021, 3B Scientific announced that it has entered into an agreement to acquire iSimulate Pty. Ltd. (“iSimulate”). "With its innovative simulation solutions, Simulate has transformed simulation training in healthcare."
What Can be Explored with the Caprylhydroxamic Acid Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Caprylhydroxamic Acid Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Caprylhydroxamic Acid
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Caprylhydroxamic Acid market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Caprylhydroxamic Acid market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Caprylhydroxamic Acid Providers, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.